Trump's FDA Pick Faces Senate Scrutiny, Supports Vaccine Adviser Role
2025-03-06
Reuters
President Donald Trump's nominee to lead the FDA, Martin Makary, testified before the Senate, expressing support for a committee of vaccine advisers. Makary's guarded appearance comes as the FDA faces increasing scrutiny over its handling of vaccine approvals and coronavirus response. With vaccine development and pharmaceutical regulation at the forefront, Makary's stance on vaccine advisers could impact public health policy and the future of vaccine distribution. The FDA nominee's comments were seen as a positive step towards increased transparency and collaboration between regulatory agencies and vaccine experts, potentially shaping the course of healthcare and medical research.